img

Global Human Papillomavirus (HPV) Testing Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Human Papillomavirus (HPV) Testing Market Research Report 2024

HPV infectionscaninfect thegenitalareasof menincludingtheskinonandaroundthepenisoranus. Theseinfectionscanalso bespreadto themoutHandthethroat. EvenwhenHPV infectionsarepersistent to themalepopulationandcancauseseverediseasessucHasgenitalwarts, analcancers, penilecancers, andcancersof theoropharynx, thereiscurrentlyno HPV test recommendformen. Theapprovedtestsavailableinthemarket areforscreeningwomenforcervicalcancers. Theyarenot usefulforthescreeningof HPV-relatedcancersorgenitalwartsinmen.
According to MRAResearch’s new survey, global Human Papillomavirus (HPV) Testing market is projected to reach US$ 1103.2 million in 2033, increasing from US$ 757 million in 2022, with the CAGR of 5.4% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Human Papillomavirus (HPV) Testing market research.
Key companies engaged in the Human Papillomavirus (HPV) Testing industry include Roche, Agilent Technologies, Becton, DickinsonandCompany, QiagenN.V., Thermo FisherScientificInc., Abbott Laboratories, HologicInc., CepheidInc. and SeegeneInc., etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Human Papillomavirus (HPV) Testing were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Human Papillomavirus (HPV) Testing market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Human Papillomavirus (HPV) Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Roche
Agilent Technologies
Becton, DickinsonandCompany
QiagenN.V.
Thermo FisherScientificInc.
Abbott Laboratories
HologicInc.
CepheidInc.
SeegeneInc.
TakaraBio Inc.
DaAnGeneof SunYat-SenUniversity
PromegaCorporation
GreinerBio-OneInternationalGmbH(GreinerHoldingAG)
Enzo Biochem Inc.
NorgenBiotek
DiagCorBioscienceIncLtd
Hybribio Limited
ZytovisionGmbH
ArborVitaCorporation
Medical& BiologicalLaboratoriesCo., Ltd
Fujirebio Diagnostics
Segment by Type
Pap Smear Test
HPV DNA Test

Segment by Application


Diagnostic Centers
Hospitals
Clinic
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Human Papillomavirus (HPV) Testing report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Papillomavirus (HPV) Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Pap Smear Test
1.2.3 HPV DNA Test
1.3 Market by Application
1.3.1 Global Human Papillomavirus (HPV) Testing Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Diagnostic Centers
1.3.3 Hospitals
1.3.4 Clinic
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Human Papillomavirus (HPV) Testing Market Perspective (2018-2033)
2.2 Human Papillomavirus (HPV) Testing Growth Trends by Region
2.2.1 Global Human Papillomavirus (HPV) Testing Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Human Papillomavirus (HPV) Testing Historic Market Size by Region (2018-2023)
2.2.3 Human Papillomavirus (HPV) Testing Forecasted Market Size by Region (2024-2033)
2.3 Human Papillomavirus (HPV) Testing Market Dynamics
2.3.1 Human Papillomavirus (HPV) Testing Industry Trends
2.3.2 Human Papillomavirus (HPV) Testing Market Drivers
2.3.3 Human Papillomavirus (HPV) Testing Market Challenges
2.3.4 Human Papillomavirus (HPV) Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human Papillomavirus (HPV) Testing Players by Revenue
3.1.1 Global Top Human Papillomavirus (HPV) Testing Players by Revenue (2018-2023)
3.1.2 Global Human Papillomavirus (HPV) Testing Revenue Market Share by Players (2018-2023)
3.2 Global Human Papillomavirus (HPV) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Human Papillomavirus (HPV) Testing Revenue
3.4 Global Human Papillomavirus (HPV) Testing Market Concentration Ratio
3.4.1 Global Human Papillomavirus (HPV) Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Papillomavirus (HPV) Testing Revenue in 2022
3.5 Human Papillomavirus (HPV) Testing Key Players Head office and Area Served
3.6 Key Players Human Papillomavirus (HPV) Testing Product Solution and Service
3.7 Date of Enter into Human Papillomavirus (HPV) Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Human Papillomavirus (HPV) Testing Breakdown Data by Type
4.1 Global Human Papillomavirus (HPV) Testing Historic Market Size by Type (2018-2023)
4.2 Global Human Papillomavirus (HPV) Testing Forecasted Market Size by Type (2024-2033)
5 Human Papillomavirus (HPV) Testing Breakdown Data by Application
5.1 Global Human Papillomavirus (HPV) Testing Historic Market Size by Application (2018-2023)
5.2 Global Human Papillomavirus (HPV) Testing Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Human Papillomavirus (HPV) Testing Market Size (2018-2033)
6.2 North America Human Papillomavirus (HPV) Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Human Papillomavirus (HPV) Testing Market Size by Country (2018-2023)
6.4 North America Human Papillomavirus (HPV) Testing Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Human Papillomavirus (HPV) Testing Market Size (2018-2033)
7.2 Europe Human Papillomavirus (HPV) Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Human Papillomavirus (HPV) Testing Market Size by Country (2018-2023)
7.4 Europe Human Papillomavirus (HPV) Testing Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Human Papillomavirus (HPV) Testing Market Size (2018-2033)
8.2 Asia-Pacific Human Papillomavirus (HPV) Testing Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Human Papillomavirus (HPV) Testing Market Size by Region (2018-2023)
8.4 Asia-Pacific Human Papillomavirus (HPV) Testing Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Human Papillomavirus (HPV) Testing Market Size (2018-2033)
9.2 Latin America Human Papillomavirus (HPV) Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Human Papillomavirus (HPV) Testing Market Size by Country (2018-2023)
9.4 Latin America Human Papillomavirus (HPV) Testing Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human Papillomavirus (HPV) Testing Market Size (2018-2033)
10.2 Middle East & Africa Human Papillomavirus (HPV) Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Human Papillomavirus (HPV) Testing Market Size by Country (2018-2023)
10.4 Middle East & Africa Human Papillomavirus (HPV) Testing Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Human Papillomavirus (HPV) Testing Introduction
11.1.4 Roche Revenue in Human Papillomavirus (HPV) Testing Business (2018-2023)
11.1.5 Roche Recent Development
11.2 Agilent Technologies
11.2.1 Agilent Technologies Company Detail
11.2.2 Agilent Technologies Business Overview
11.2.3 Agilent Technologies Human Papillomavirus (HPV) Testing Introduction
11.2.4 Agilent Technologies Revenue in Human Papillomavirus (HPV) Testing Business (2018-2023)
11.2.5 Agilent Technologies Recent Development
11.3 Becton, DickinsonandCompany
11.3.1 Becton, DickinsonandCompany Company Detail
11.3.2 Becton, DickinsonandCompany Business Overview
11.3.3 Becton, DickinsonandCompany Human Papillomavirus (HPV) Testing Introduction
11.3.4 Becton, DickinsonandCompany Revenue in Human Papillomavirus (HPV) Testing Business (2018-2023)
11.3.5 Becton, DickinsonandCompany Recent Development
11.4 QiagenN.V.
11.4.1 QiagenN.V. Company Detail
11.4.2 QiagenN.V. Business Overview
11.4.3 QiagenN.V. Human Papillomavirus (HPV) Testing Introduction
11.4.4 QiagenN.V. Revenue in Human Papillomavirus (HPV) Testing Business (2018-2023)
11.4.5 QiagenN.V. Recent Development
11.5 Thermo FisherScientificInc.
11.5.1 Thermo FisherScientificInc. Company Detail
11.5.2 Thermo FisherScientificInc. Business Overview
11.5.3 Thermo FisherScientificInc. Human Papillomavirus (HPV) Testing Introduction
11.5.4 Thermo FisherScientificInc. Revenue in Human Papillomavirus (HPV) Testing Business (2018-2023)
11.5.5 Thermo FisherScientificInc. Recent Development
11.6 Abbott Laboratories
11.6.1 Abbott Laboratories Company Detail
11.6.2 Abbott Laboratories Business Overview
11.6.3 Abbott Laboratories Human Papillomavirus (HPV) Testing Introduction
11.6.4 Abbott Laboratories Revenue in Human Papillomavirus (HPV) Testing Business (2018-2023)
11.6.5 Abbott Laboratories Recent Development
11.7 HologicInc.
11.7.1 HologicInc. Company Detail
11.7.2 HologicInc. Business Overview
11.7.3 HologicInc. Human Papillomavirus (HPV) Testing Introduction
11.7.4 HologicInc. Revenue in Human Papillomavirus (HPV) Testing Business (2018-2023)
11.7.5 HologicInc. Recent Development
11.8 CepheidInc.
11.8.1 CepheidInc. Company Detail
11.8.2 CepheidInc. Business Overview
11.8.3 CepheidInc. Human Papillomavirus (HPV) Testing Introduction
11.8.4 CepheidInc. Revenue in Human Papillomavirus (HPV) Testing Business (2018-2023)
11.8.5 CepheidInc. Recent Development
11.9 SeegeneInc.
11.9.1 SeegeneInc. Company Detail
11.9.2 SeegeneInc. Business Overview
11.9.3 SeegeneInc. Human Papillomavirus (HPV) Testing Introduction
11.9.4 SeegeneInc. Revenue in Human Papillomavirus (HPV) Testing Business (2018-2023)
11.9.5 SeegeneInc. Recent Development
11.10 TakaraBio Inc.
11.10.1 TakaraBio Inc. Company Detail
11.10.2 TakaraBio Inc. Business Overview
11.10.3 TakaraBio Inc. Human Papillomavirus (HPV) Testing Introduction
11.10.4 TakaraBio Inc. Revenue in Human Papillomavirus (HPV) Testing Business (2018-2023)
11.10.5 TakaraBio Inc. Recent Development
11.11 DaAnGeneof SunYat-SenUniversity
11.11.1 DaAnGeneof SunYat-SenUniversity Company Detail
11.11.2 DaAnGeneof SunYat-SenUniversity Business Overview
11.11.3 DaAnGeneof SunYat-SenUniversity Human Papillomavirus (HPV) Testing Introduction
11.11.4 DaAnGeneof SunYat-SenUniversity Revenue in Human Papillomavirus (HPV) Testing Business (2018-2023)
11.11.5 DaAnGeneof SunYat-SenUniversity Recent Development
11.12 PromegaCorporation
11.12.1 PromegaCorporation Company Detail
11.12.2 PromegaCorporation Business Overview
11.12.3 PromegaCorporation Human Papillomavirus (HPV) Testing Introduction
11.12.4 PromegaCorporation Revenue in Human Papillomavirus (HPV) Testing Business (2018-2023)
11.12.5 PromegaCorporation Recent Development
11.13 GreinerBio-OneInternationalGmbH(GreinerHoldingAG)
11.13.1 GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Company Detail
11.13.2 GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Business Overview
11.13.3 GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Human Papillomavirus (HPV) Testing Introduction
11.13.4 GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Revenue in Human Papillomavirus (HPV) Testing Business (2018-2023)
11.13.5 GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Recent Development
11.14 Enzo Biochem Inc.
11.14.1 Enzo Biochem Inc. Company Detail
11.14.2 Enzo Biochem Inc. Business Overview
11.14.3 Enzo Biochem Inc. Human Papillomavirus (HPV) Testing Introduction
11.14.4 Enzo Biochem Inc. Revenue in Human Papillomavirus (HPV) Testing Business (2018-2023)
11.14.5 Enzo Biochem Inc. Recent Development
11.15 NorgenBiotek
11.15.1 NorgenBiotek Company Detail
11.15.2 NorgenBiotek Business Overview
11.15.3 NorgenBiotek Human Papillomavirus (HPV) Testing Introduction
11.15.4 NorgenBiotek Revenue in Human Papillomavirus (HPV) Testing Business (2018-2023)
11.15.5 NorgenBiotek Recent Development
11.16 DiagCorBioscienceIncLtd
11.16.1 DiagCorBioscienceIncLtd Company Detail
11.16.2 DiagCorBioscienceIncLtd Business Overview
11.16.3 DiagCorBioscienceIncLtd Human Papillomavirus (HPV) Testing Introduction
11.16.4 DiagCorBioscienceIncLtd Revenue in Human Papillomavirus (HPV) Testing Business (2018-2023)
11.16.5 DiagCorBioscienceIncLtd Recent Development
11.17 Hybribio Limited
11.17.1 Hybribio Limited Company Detail
11.17.2 Hybribio Limited Business Overview
11.17.3 Hybribio Limited Human Papillomavirus (HPV) Testing Introduction
11.17.4 Hybribio Limited Revenue in Human Papillomavirus (HPV) Testing Business (2018-2023)
11.17.5 Hybribio Limited Recent Development
11.18 ZytovisionGmbH
11.18.1 ZytovisionGmbH Company Detail
11.18.2 ZytovisionGmbH Business Overview
11.18.3 ZytovisionGmbH Human Papillomavirus (HPV) Testing Introduction
11.18.4 ZytovisionGmbH Revenue in Human Papillomavirus (HPV) Testing Business (2018-2023)
11.18.5 ZytovisionGmbH Recent Development
11.19 ArborVitaCorporation
11.19.1 ArborVitaCorporation Company Detail
11.19.2 ArborVitaCorporation Business Overview
11.19.3 ArborVitaCorporation Human Papillomavirus (HPV) Testing Introduction
11.19.4 ArborVitaCorporation Revenue in Human Papillomavirus (HPV) Testing Business (2018-2023)
11.19.5 ArborVitaCorporation Recent Development
11.20 Medical& BiologicalLaboratoriesCo., Ltd
11.20.1 Medical& BiologicalLaboratoriesCo., Ltd Company Detail
11.20.2 Medical& BiologicalLaboratoriesCo., Ltd Business Overview
11.20.3 Medical& BiologicalLaboratoriesCo., Ltd Human Papillomavirus (HPV) Testing Introduction
11.20.4 Medical& BiologicalLaboratoriesCo., Ltd Revenue in Human Papillomavirus (HPV) Testing Business (2018-2023)
11.20.5 Medical& BiologicalLaboratoriesCo., Ltd Recent Development
11.21 Fujirebio Diagnostics
11.21.1 Fujirebio Diagnostics Company Detail
11.21.2 Fujirebio Diagnostics Business Overview
11.21.3 Fujirebio Diagnostics Human Papillomavirus (HPV) Testing Introduction
11.21.4 Fujirebio Diagnostics Revenue in Human Papillomavirus (HPV) Testing Business (2018-2023)
11.21.5 Fujirebio Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Human Papillomavirus (HPV) Testing Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Pap Smear Test
Table 3. Key Players of HPV DNA Test
Table 4. Global Human Papillomavirus (HPV) Testing Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Human Papillomavirus (HPV) Testing Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Human Papillomavirus (HPV) Testing Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Human Papillomavirus (HPV) Testing Market Share by Region (2018-2023)
Table 8. Global Human Papillomavirus (HPV) Testing Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Human Papillomavirus (HPV) Testing Market Share by Region (2024-2033)
Table 10. Human Papillomavirus (HPV) Testing Market Trends
Table 11. Human Papillomavirus (HPV) Testing Market Drivers
Table 12. Human Papillomavirus (HPV) Testing Market Challenges
Table 13. Human Papillomavirus (HPV) Testing Market Restraints
Table 14. Global Human Papillomavirus (HPV) Testing Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Human Papillomavirus (HPV) Testing Market Share by Players (2018-2023)
Table 16. Global Top Human Papillomavirus (HPV) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Papillomavirus (HPV) Testing as of 2022)
Table 17. Ranking of Global Top Human Papillomavirus (HPV) Testing Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Human Papillomavirus (HPV) Testing Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Human Papillomavirus (HPV) Testing Product Solution and Service
Table 21. Date of Enter into Human Papillomavirus (HPV) Testing Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Human Papillomavirus (HPV) Testing Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Human Papillomavirus (HPV) Testing Revenue Market Share by Type (2018-2023)
Table 25. Global Human Papillomavirus (HPV) Testing Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Human Papillomavirus (HPV) Testing Revenue Market Share by Type (2024-2033)
Table 27. Global Human Papillomavirus (HPV) Testing Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Human Papillomavirus (HPV) Testing Revenue Market Share by Application (2018-2023)
Table 29. Global Human Papillomavirus (HPV) Testing Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Human Papillomavirus (HPV) Testing Revenue Market Share by Application (2024-2033)
Table 31. North America Human Papillomavirus (HPV) Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Human Papillomavirus (HPV) Testing Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Human Papillomavirus (HPV) Testing Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Human Papillomavirus (HPV) Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Human Papillomavirus (HPV) Testing Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Human Papillomavirus (HPV) Testing Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Human Papillomavirus (HPV) Testing Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Human Papillomavirus (HPV) Testing Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Human Papillomavirus (HPV) Testing Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Human Papillomavirus (HPV) Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Human Papillomavirus (HPV) Testing Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Human Papillomavirus (HPV) Testing Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Human Papillomavirus (HPV) Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Human Papillomavirus (HPV) Testing Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Human Papillomavirus (HPV) Testing Market Size by Country (2024-2033) & (US$ Million)
Table 46. Roche Company Detail
Table 47. Roche Business Overview
Table 48. Roche Human Papillomavirus (HPV) Testing Product
Table 49. Roche Revenue in Human Papillomavirus (HPV) Testing Business (2018-2023) & (US$ Million)
Table 50. Roche Recent Development
Table 51. Agilent Technologies Company Detail
Table 52. Agilent Technologies Business Overview
Table 53. Agilent Technologies Human Papillomavirus (HPV) Testing Product
Table 54. Agilent Technologies Revenue in Human Papillomavirus (HPV) Testing Business (2018-2023) & (US$ Million)
Table 55. Agilent Technologies Recent Development
Table 56. Becton, DickinsonandCompany Company Detail
Table 57. Becton, DickinsonandCompany Business Overview
Table 58. Becton, DickinsonandCompany Human Papillomavirus (HPV) Testing Product
Table 59. Becton, DickinsonandCompany Revenue in Human Papillomavirus (HPV) Testing Business (2018-2023) & (US$ Million)
Table 60. Becton, DickinsonandCompany Recent Development
Table 61. QiagenN.V. Company Detail
Table 62. QiagenN.V. Business Overview
Table 63. QiagenN.V. Human Papillomavirus (HPV) Testing Product
Table 64. QiagenN.V. Revenue in Human Papillomavirus (HPV) Testing Business (2018-2023) & (US$ Million)
Table 65. QiagenN.V. Recent Development
Table 66. Thermo FisherScientificInc. Company Detail
Table 67. Thermo FisherScientificInc. Business Overview
Table 68. Thermo FisherScientificInc. Human Papillomavirus (HPV) Testing Product
Table 69. Thermo FisherScientificInc. Revenue in Human Papillomavirus (HPV) Testing Business (2018-2023) & (US$ Million)
Table 70. Thermo FisherScientificInc. Recent Development
Table 71. Abbott Laboratories Company Detail
Table 72. Abbott Laboratories Business Overview
Table 73. Abbott Laboratories Human Papillomavirus (HPV) Testing Product
Table 74. Abbott Laboratories Revenue in Human Papillomavirus (HPV) Testing Business (2018-2023) & (US$ Million)
Table 75. Abbott Laboratories Recent Development
Table 76. HologicInc. Company Detail
Table 77. HologicInc. Business Overview
Table 78. HologicInc. Human Papillomavirus (HPV) Testing Product
Table 79. HologicInc. Revenue in Human Papillomavirus (HPV) Testing Business (2018-2023) & (US$ Million)
Table 80. HologicInc. Recent Development
Table 81. CepheidInc. Company Detail
Table 82. CepheidInc. Business Overview
Table 83. CepheidInc. Human Papillomavirus (HPV) Testing Product
Table 84. CepheidInc. Revenue in Human Papillomavirus (HPV) Testing Business (2018-2023) & (US$ Million)
Table 85. CepheidInc. Recent Development
Table 86. SeegeneInc. Company Detail
Table 87. SeegeneInc. Business Overview
Table 88. SeegeneInc. Human Papillomavirus (HPV) Testing Product
Table 89. SeegeneInc. Revenue in Human Papillomavirus (HPV) Testing Business (2018-2023) & (US$ Million)
Table 90. SeegeneInc. Recent Development
Table 91. TakaraBio Inc. Company Detail
Table 92. TakaraBio Inc. Business Overview
Table 93. TakaraBio Inc. Human Papillomavirus (HPV) Testing Product
Table 94. TakaraBio Inc. Revenue in Human Papillomavirus (HPV) Testing Business (2018-2023) & (US$ Million)
Table 95. TakaraBio Inc. Recent Development
Table 96. DaAnGeneof SunYat-SenUniversity Company Detail
Table 97. DaAnGeneof SunYat-SenUniversity Business Overview
Table 98. DaAnGeneof SunYat-SenUniversity Human Papillomavirus (HPV) Testing Product
Table 99. DaAnGeneof SunYat-SenUniversity Revenue in Human Papillomavirus (HPV) Testing Business (2018-2023) & (US$ Million)
Table 100. DaAnGeneof SunYat-SenUniversity Recent Development
Table 101. PromegaCorporation Company Detail
Table 102. PromegaCorporation Business Overview
Table 103. PromegaCorporation Human Papillomavirus (HPV) Testing Product
Table 104. PromegaCorporation Revenue in Human Papillomavirus (HPV) Testing Business (2018-2023) & (US$ Million)
Table 105. PromegaCorporation Recent Development
Table 106. GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Company Detail
Table 107. GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Business Overview
Table 108. GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Human Papillomavirus (HPV) Testing Product
Table 109. GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Revenue in Human Papillomavirus (HPV) Testing Business (2018-2023) & (US$ Million)
Table 110. GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Recent Development
Table 111. Enzo Biochem Inc. Company Detail
Table 112. Enzo Biochem Inc. Business Overview
Table 113. Enzo Biochem Inc. Human Papillomavirus (HPV) Testing Product
Table 114. Enzo Biochem Inc. Revenue in Human Papillomavirus (HPV) Testing Business (2018-2023) & (US$ Million)
Table 115. Enzo Biochem Inc. Recent Development
Table 116. NorgenBiotek Company Detail
Table 117. NorgenBiotek Business Overview
Table 118. NorgenBiotek Human Papillomavirus (HPV) Testing Product
Table 119. NorgenBiotek Revenue in Human Papillomavirus (HPV) Testing Business (2018-2023) & (US$ Million)
Table 120. NorgenBiotek Recent Development
Table 121. DiagCorBioscienceIncLtd Company Detail
Table 122. DiagCorBioscienceIncLtd Business Overview
Table 123. DiagCorBioscienceIncLtd Human Papillomavirus (HPV) Testing Product
Table 124. DiagCorBioscienceIncLtd Revenue in Human Papillomavirus (HPV) Testing Business (2018-2023) & (US$ Million)
Table 125. DiagCorBioscienceIncLtd Recent Development
Table 126. Hybribio Limited Company Detail
Table 127. Hybribio Limited Business Overview
Table 128. Hybribio Limited Human Papillomavirus (HPV) Testing Product
Table 129. Hybribio Limited Revenue in Human Papillomavirus (HPV) Testing Business (2018-2023) & (US$ Million)
Table 130. Hybribio Limited Recent Development
Table 131. ZytovisionGmbH Company Detail
Table 132. ZytovisionGmbH Business Overview
Table 133. ZytovisionGmbH Human Papillomavirus (HPV) Testing Product
Table 134. ZytovisionGmbH Revenue in Human Papillomavirus (HPV) Testing Business (2018-2023) & (US$ Million)
Table 135. ZytovisionGmbH Recent Development
Table 136. ArborVitaCorporation Company Detail
Table 137. ArborVitaCorporation Business Overview
Table 138. ArborVitaCorporation Human Papillomavirus (HPV) Testing Product
Table 139. ArborVitaCorporation Revenue in Human Papillomavirus (HPV) Testing Business (2018-2023) & (US$ Million)
Table 140. ArborVitaCorporation Recent Development
Table 141. Medical& BiologicalLaboratoriesCo., Ltd Company Detail
Table 142. Medical& BiologicalLaboratoriesCo., Ltd Business Overview
Table 143. Medical& BiologicalLaboratoriesCo., Ltd Human Papillomavirus (HPV) Testing Product
Table 144. Medical& BiologicalLaboratoriesCo., Ltd Revenue in Human Papillomavirus (HPV) Testing Business (2018-2023) & (US$ Million)
Table 145. Medical& BiologicalLaboratoriesCo., Ltd Recent Development
Table 146. Fujirebio Diagnostics Company Detail
Table 147. Fujirebio Diagnostics Business Overview
Table 148. Fujirebio Diagnostics Human Papillomavirus (HPV) Testing Product
Table 149. Fujirebio Diagnostics Revenue in Human Papillomavirus (HPV) Testing Business (2018-2023) & (US$ Million)
Table 150. Fujirebio Diagnostics Recent Development
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Human Papillomavirus (HPV) Testing Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Human Papillomavirus (HPV) Testing Market Share by Type: 2022 VS 2033
Figure 3. Pap Smear Test Features
Figure 4. HPV DNA Test Features
Figure 5. Global Human Papillomavirus (HPV) Testing Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Human Papillomavirus (HPV) Testing Market Share by Application: 2022 VS 2033
Figure 7. Diagnostic Centers Case Studies
Figure 8. Hospitals Case Studies
Figure 9. Clinic Case Studies
Figure 10. Human Papillomavirus (HPV) Testing Report Years Considered
Figure 11. Global Human Papillomavirus (HPV) Testing Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Human Papillomavirus (HPV) Testing Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Human Papillomavirus (HPV) Testing Market Share by Region: 2022 VS 2033
Figure 14. Global Human Papillomavirus (HPV) Testing Market Share by Players in 2022
Figure 15. Global Top Human Papillomavirus (HPV) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Papillomavirus (HPV) Testing as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Human Papillomavirus (HPV) Testing Revenue in 2022
Figure 17. North America Human Papillomavirus (HPV) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Human Papillomavirus (HPV) Testing Market Share by Country (2018-2033)
Figure 19. United States Human Papillomavirus (HPV) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Human Papillomavirus (HPV) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Human Papillomavirus (HPV) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Human Papillomavirus (HPV) Testing Market Share by Country (2018-2033)
Figure 23. Germany Human Papillomavirus (HPV) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Human Papillomavirus (HPV) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Human Papillomavirus (HPV) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Human Papillomavirus (HPV) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Human Papillomavirus (HPV) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Human Papillomavirus (HPV) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Human Papillomavirus (HPV) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Human Papillomavirus (HPV) Testing Market Share by Region (2018-2033)
Figure 31. China Human Papillomavirus (HPV) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Human Papillomavirus (HPV) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Human Papillomavirus (HPV) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Human Papillomavirus (HPV) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Human Papillomavirus (HPV) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Human Papillomavirus (HPV) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Human Papillomavirus (HPV) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Human Papillomavirus (HPV) Testing Market Share by Country (2018-2033)
Figure 39. Mexico Human Papillomavirus (HPV) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Human Papillomavirus (HPV) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Human Papillomavirus (HPV) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Human Papillomavirus (HPV) Testing Market Share by Country (2018-2033)
Figure 43. Turkey Human Papillomavirus (HPV) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Human Papillomavirus (HPV) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Roche Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2018-2023)
Figure 46. Agilent Technologies Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2018-2023)
Figure 47. Becton, DickinsonandCompany Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2018-2023)
Figure 48. QiagenN.V. Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2018-2023)
Figure 49. Thermo FisherScientificInc. Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2018-2023)
Figure 50. Abbott Laboratories Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2018-2023)
Figure 51. HologicInc. Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2018-2023)
Figure 52. CepheidInc. Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2018-2023)
Figure 53. SeegeneInc. Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2018-2023)
Figure 54. TakaraBio Inc. Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2018-2023)
Figure 55. DaAnGeneof SunYat-SenUniversity Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2018-2023)
Figure 56. PromegaCorporation Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2018-2023)
Figure 57. GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2018-2023)
Figure 58. Enzo Biochem Inc. Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2018-2023)
Figure 59. NorgenBiotek Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2018-2023)
Figure 60. DiagCorBioscienceIncLtd Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2018-2023)
Figure 61. Hybribio Limited Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2018-2023)
Figure 62. ZytovisionGmbH Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2018-2023)
Figure 63. ArborVitaCorporation Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2018-2023)
Figure 64. Medical& BiologicalLaboratoriesCo., Ltd Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2018-2023)
Figure 65. Fujirebio Diagnostics Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2018-2023)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries